Filing Details
- Accession Number:
- 0001493152-21-021444
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-27 15:19:33
- Reporting Period:
- 2021-08-25
- Accepted Time:
- 2021-08-27 15:19:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661053 | Hancock Jaffe Laboratories Inc. | HJLI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1357864 | Matthew Jenusaitis | C/O Jaffe Laboratories, 70 Doppler Irvine CA 92618 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $$0.00001 Par Value | Acquisiton | 2021-08-25 | 1,300 | $7.70 | 4,842 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On August 25, 2021, the reporting person purchased 1,300 shares of common stock in the public market at $7.70 per share.
Billionaire Hedge Funds
